
4 Notable Health Tech Funding Announcements In March
Health tech companies made several major funding announcements in March. Here is a list of some of the biggest funding rounds.
Health tech companies made several major funding announcements in March. Here is a list of some of the biggest funding rounds.
Welcome to hell, here's your meme stock prospectus.
Practical Law's ‘Dynamic Tool Set’ application allows you to unleash the power of an army of attorney-experts while leveraging state-of-the-art gen AI.
Backdating moral outrage is what got Democrats into the terrible situation they're now in in the first place.
A month before 23andMe’s bankruptcy filing, CEO Anne Wojcicki had a fully financed proposal to take the genetic testing company private. The financing fell apart, and a series of alternative proposals by Wojcicki did not result in a deal.
Amid the market volatility and intense macroeconomic uncertainty, is it wise for Hinge Health to test the public markets?
You still have time to make a significant impact on your tax situation and long-term financial health.
We are looking for insights from both private practice law firms and the clients they serve.
Learn legal trust accounting best practices to ensure compliance and protect client funds. Discover expert tips to set your firm up for success.
Apparently forgetting that it is not opposite day, almost everything Trump is trying to do will raise, not lower, prices for consumers.
Many experts — be they venture capitalists or private equity investors — shared their advice with biotech entrepreneurs navigating a tough funding environment.
A 15% drop here, a 15% drop there, and soon you're talking real problems.
Corporate investment and usage in generative AI technologies continues to accelerate. This article offers eight specific tips to consider when creating an AI usage policy.
This comes after the company has faced increased competition from online retailers like Amazon. It remains to be seen, however, if Walgreens will perform better under Sycamore Partners.
Let's Make America Victorian England Again!
Health tech companies made several major funding announcements in February. Here is a list of some of the biggest funding rounds.
Wave goodbye to Biglaw, and say hello to Big Four Law!
Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million. Meanwhile, Pfizer continued the culling of its gene therapies with the discontinuation of Beqvez for hemophilia B.